UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | O | P | R | S | T | V | W | Y | Z
Number of items: 89.

A

Andrady, C and Sharma, SK and Chester, KA (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Arkenau, H-K (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? ANNALS OF ONCOLOGY , 22 (1) 239 - U282. 10.1093/annonc/mdq676.

Arkenau, HT and Kefford, R and Long, GV (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) 392 - 398. 10.1038/sj.bjc.6606030.

Arkenau, HT and Nordman, I and Dobbins, T and Ward, R (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) 832 - 840. 10.1002/cncr.25636.

B

Babu, B and Lee, M and Lee, L and Strobel, R and Brockway, O and Nickols, A and Sjoholm, R and Tzou, S and Chavda, S and Desta, D and Fraley, G and Siegfried, A and Pennington, W and Hartley, RM and Westbrook, C and Mooberry, SL and Kiakos, K and Hartley, JA and Lee, M (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B and Liu, Y and Plaunt, A and Riddering, C and Ogilvie, R and Westrate, L and Davis, R and Ferguson, A and Mackay, H and Rice, T and Chavda, S and Wilson, D and Lin, SC and Kiakos, K and Hartley, JA and Lee, M (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Babu, B and Ramos, J and Liu, Y and Chavda, S and Tzou, S and Brockway, O and Sjoholm, R and Savagian, M and Lin, S and Kiakos, K and Wilson, WD and Hartley, JA and Lee, M (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Baraniskin, A and Munding, J and Schulmann, K and Meier, D and Porschen, R and Arkenau, HT and Graeven, U and Schmiegel, W and Tannapfel, A and Reinacher-Schick, A (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) 24 - 29. 10.3816/CCC.2011.n.003.

Birkbak, NJ and Eklund, AC and Li, Q and McClelland, SE and Endesfelder, D and Tan, P and Tan, IB and Richardson, AL and Szallasi, Z and Swanton, C (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) 3447 - 3452. 10.1158/0008-5472.CAN-10-3667.

Brough, R and Frankum, JR and Sims, D and Mackay, A and Mendes-Pereira, AM and Bajrami, I and Costa-Cabral, S and Rafiq, R and Ahmad, AS and Cerone, MA and Natrajan, R and Sharpe, R and Shiu, KK and Wetterskog, D and Dedes, KJ and Lambros, MB and Rawjee, T and Linardopoulos, S and Reis-Filho, JS and Turner, NC and Lord, CJ and Ashworth, A (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) 260 - 273. 10.1158/2159-8290.CD-11-0107.

Brucoli, F and Hawkins, RM and James, CH and Wells, G and Jenkins, TC and Ellis, T and Hartley, JA and Howard, PW and Thurston, DE (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A and Olmos, D and Arkenau, HT and Tan, D and Yap, T and de Bono, J and Barriuso, J and Kaye, S (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401 - ?. 10.1155/2011/861401.

C

Calvert, AH (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Calvert, H and Azzariti, A (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cerone, MA and Burgess, DJ and Naceur-Lombardelli, C and Lord, CJ and Ashworth, A (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) 3328 - 3340. 10.1158/0008-5472.CAN-10-2734.

Chavda, S and Liu, Y and Babu, B and Davis, R and Sielaff, A and Ruprich, J and Westrate, L and Tronrud, C and Ferguson, A and Franks, A and Tzou, S and Adkins, C and Rice, T and Mackay, H and Kluza, J and Tahir, SA and Lin, S and Kiakos, K and Bruce, CD and Wilson, WD and Hartley, JA and Lee, M (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Chavda, S and Liu, Y and Babu, B and Davis, R and Sielaff, A and Ruprich, J and Westrate, L and Tronrud, C and Ferguson, A and Franks, A and Tzou, S and Adkins, C and Rice, T and Mackay, H and Kluza, J and Tahir, SA and Lin, SC and Kiakos, K and Bruce, CD and Wilson, WD and Hartley, JA and Lee, M (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Chew, SK and Rad, R and Futreal, PA and Bradley, A and Liu, P (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) 366 - 371. 10.1016/j.ymeth.2010.12.022.

Coward, J and Kulbe, H and Chakravarty, P and Leader, D and Vassileva, V and Leinster, DA and Thompson, R and Schioppa, T and Nemeth, J and Vermeulen, J and Singh, N and Avril, N and Cummings, J and Rexhepaj, E and Jirstrom, K and Gallagher, WM and Brennan, DJ and McNeish, IA and Balkwill, FR (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLIN CANCER RES , 17 (18) 6083 - 6096. 10.1158/1078-0432.CCR-11-0945.

Cox, ST and Stephens, HAF and Fernando, R and Karasu, A and Harber, M and Howie, AJ and Powis, S and Zou, Y and Stastny, P and Madrigal, JA and Little, A-M (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. HUMAN IMMUNOLOGY , 72 (10) 827 - 834. 10.1016/j.humimm.2011.05.004.

D

De Bono, JS and Logothetis, CJ and Molina, A and Fizazi, K and North, S and Chu, L and Chi, KN and Jones, RJ and Goodman, OB and Saad, F and Staffurth, JN and Mainwaring, P and Harland, S and Flaig, TW and Hutson, TE and Cheng, T and Patterson, H and Hainsworth, JD and Ryan, CJ and Sternberg, CN and Ellard, SL and Flechon, A and Saleh, M and Scholz, M and Efstathiou, E and Zivi, A and Bianchini, D and Loriot, Y and Chieffo, N and Kheoh, T and Haqq, CM and Scher, HI and COU-AA-301 Investigators, (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGL J MED , 364 (21) 1995 - 2005.

E

Ertemi, H and Mumtaz, FH and Howie, AJ and Mikhailidis, DP and Thompson, CS (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

F

Forster, MD and Dedes, K and Sandhu, S and Frentzas, S and Kristeleit, R and Ashworth, A and Poole, C and Weigelt, B and Kaye, SB and Molife, LR (2011) Treatment with the PARP inhibitor olaparib in a patient with PTEN-deficient endometrial cancer. Nature Reviews Clinical Oncology , 8 (5) 302 - 306.

Forster, MD and Dedes, KJ and Sandhu, S and Frentzas, S and Kristeleit, R and Ashworth, A and Poole, CJ and Weigelt, B and Kaye, SB and Molife, LR (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) 302 - 306. 10.1038/nrclinonc.2011.42.

Furstenberg, A and Walsh, SB and Howie, A and Jones, G and Unwin, RJ (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

Furuse, J and Okusaka, T and Bridgewater, J and Taketsuna, M and Wasan, H and Koshiji, M and Valle, J (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Crit Rev Oncol Hematol , 80 (1) 31 - 39. 10.1016/j.critrevonc.2010.10.009.

G

Gillmore, R and Stuart, S and Kirkwood, A and Hameeduddin, A and Woodward, N and Burroughs, AK and Meyer, T (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol , 55 (6) 1309 - 1316. 10.1016/j.jhep.2011.03.007.

Goldstein, R and Meyer, T (2011) Role of everolimus in pancreatic neuroendocrine tumors. Expert Rev Anticancer Ther , 11 (11) 1653 - 1665. 10.1586/era.11.145.

Greimel, E and Nordin, A and Lanceley, A and Creutzberg, CL and Van De Poll-Franse, LV and Radisic, VB and Galalae, R and Schmalz, C and Barlow, E and Jensen, PT and Waldenström, A-C and Bergmark, K and Chie, W-C and Kuljanic, K and Costantini, A and Singer, S and Koensgen, D and Menon, U and Daghofer, F (2011) Psychometric validation of the European organisation for research and treatment of cancer quality of life questionnaire-endometrial cancer module (EORTC QLQ-EN24). European Journal of Cancer , 47 (2) 183 - 190.

Grimmett, C and Bridgewater, J and Steptoe, A and Wardle, J (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

H

Hartley, JA (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM and Spanswick, VJ and Hartley, JA (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 309 - 320. 10.1007/978-1-61779-080-5_25.

Holme, H and Nanduri, V (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) 150 - 151. 10.1111/j.1440-1754.2010.01741.x.

Hoorn, EJ and Walsh, SB and McCormick, JA and Furstenberg, A and Yang, CL and Roeschel, T and Paliege, A and Howie, AJ and Conley, J and Bachmann, S and Unwin, RJ and Ellison, DH (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

Howie, AJ (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) 1197 - 1205. 10.1007/s00467-010-1701-0.

J

Juergens, H and Daw, NC and Geoerger, B and Ferrari, S and Villarroel, M and Aerts, I and Whelan, J and Dirksen, U and Hixon, ML and Yin, D and Wang, T and Green, S and Paccagnella, L and Gualberto, A (2011) Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol , 29 (34) 4534 - 4540. 10.1200/JCO.2010.33.0670.

K

Kato, H and Seto, K and Kobayashi, N and Yoshinaga, K and Meyer, T and Takei, M (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Khan, MS and El-Khouly, F and Toumpanakis, C and Meyer, T and Caplin, M and Luong, TV (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: NEUROENDOCRINOLOGY. (pp. 31 - 31).

Khan, MS and Tsigani, T and Garcia-Hernandez, J and Caplin, M and Meyer, T (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: NEUROENDOCRINOLOGY. (pp. 31 - 31).

Khan, MS and Tsigani, T and Rashid, M and Rabouhans, JS and Yu, D and Tu, VL and Caplin, M and Meyer, T (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

Kristeleit, RS and baird, R and venugopal, B and wilkins, D and maccormick, F and granata, R and crawford, D and charlton, J and camm, J and hellemans, P and fourneau, N and elsayed, Y and cowan, R and banerji, U and plummer, R and evans, J and de bono, J (2011) Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer. In: Molecular Cancer Therapeutics.

L

Lee, AJ and Endesfelder, D and Rowan, AJ and Walther, A and Birkbak, NJ and Futreal, PA and Downward, J and Szallasi, Z and Tomlinson, IP and Howell, M and Kschischo, M and Swanton, C (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) 1858 - 1870. 10.1158/0008-5472.CAN-10-3604.

Lemech, C and Arkenau, H-T (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) 1844 - 1860.
An open access publication

Lemech, CR and Kristeleit, RS and Arkenau, H (2011) Novel Oncology drug development strategies in the era of personalised medicine. In: Drug Discovery and Development. InTech

Leoni, LM and Hartley, JA (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Liccardi, G and Hartley, JA and Hochhauser, D (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384.
An open access publication

Liccardi, G. (2011) Nuclear EGFR modulation of DNA repair. Doctoral thesis, UCL (University College London).
An open access version is available from UCL Discovery
 file

Liu, H and Wang, W and Chew, SK and Lee, SC and Li, J and Vassiliou, GS and Green, T and Futreal, PA and Bradley, A and Zhang, S and Liu, P (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) 689 - 695. 10.1002/dvg.20741.

Lolkema, MP and Arkenau, HT and Harrington, K and Roxburgh, P and Morrison, R and Roulstone, V and Twigger, K and Coffey, M and Mettinger, K and Gill, G and Evans, TR and de Bono, JS (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) 581 - 588. 10.1158/1078-0432.CCR-10-2159.

Lowe, H.L. (2011) Design, construction and evaluation of a humanised ADEPT system. Doctoral thesis, UCL (University College London).

M

Mahadevan, D and Plummer, R and Squires, MS and Rensvold, D and Kurtin, S and Pretzinger, C and Dragovich, T and Adams, J and Lock, V and Smith, DM and Von Hoff, D and Calvert, H (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Mansur, A and Little, MA and Oh, WC and Jacques, S and Nightingale, P and Howie, AJ and Savage, CO (2011) Immune profile and Epstein-Barr virus infection in acute interstitial nephritis: an immunohistochemical study in 78 patients. Nephron Clin Pract , 119 (4) c293 - c300. 10.1159/000329671.

Marsh, D and Suchak, K and Moutasim, KA and Vallath, S and Hopper, C and Jerjes, W and Upile, T and Kalavrezos, N and Violette, SM and Weinreb, PH and Chester, KA and Chana, JS and Marshall, JF and Hart, IR and Hackshaw, AK and Piper, K and Thomas, GJ (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Maughan, TS and Adams, RA and Smith, CG and Meade, AM and Seymour, MT and Wilson, RH and Idziaszczyk, S and Harris, R and Fisher, D and Kenny, SL and Kay, E and Mitchell, JK and Madi, A and Jasani, B and James, MD and Bridgewater, J and Kennedy, MJ and Claes, B and Lambrechts, D and Kaplan, R and Cheadle, JP and MRC COIN Trial Investigators, (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. LANCET , 377 (9783) 2103 - 2114. 10.1016/S0140-6736(11)60613-2.

Maughan, TS and Adams, RA and Smith, CG and Meade, AM and Seymour, MT and Wilson, RH and Idziaszczyk, S and Harris, R and Fisher, D and Kenny, SL and Kay, E and Mitchell, JK and Madi, A and Jasani, B and James, MD and Bridgewater, J and Kennedy, MJ and Claes, B and Lambrechts, D and Kaplan, R and Cheadle, JP and MRC COIN Trial Investigators, (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) 2103 - 2114. 10.1016/S0140-6736(11)60613-2.

Melichar, B and Casado, E and Bridgewater, J and Bennouna, J and Campone, M and Vitek, P and Delord, JP and Cerman, J and Salazar, R and Dvorak, J and Sguotti, C and Urban, P and Viraswami-Appanna, K and Tan, E and Tabernero, J (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. Br J Cancer , 105 (11) 1646 - 1653. 10.1038/bjc.2011.438.

Meyer, C and Sevko, A and Ramacher, M and Bazhin, AV and Falk, CS and Osen, W and Borrello, I and Kato, M and Schadendorf, D and Baniyash, M and Umansky, V (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) 17111 - 17116. 10.1073/pnas.1108121108.

O

Osawa, T and Davies, D and Hartley, JA (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70.
An open access publication

P

Pors, K and Loadman, PM and Shnyder, SD and Sutherland, M and Sheldrake, HM and Guino, M and Kiakos, K and Hartley, JA and Searcey, M and Patterson, LH (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Pacey, S and Wilson, RH and Walton, M and Eatock, MM and Hardcastle, A and Zetterlund, A and Arkenau, HT and Moreno-Farre, J and Banerji, U and Roels, B and Peachey, H and Aherne, W and de Bono, JS and Raynaud, F and Workman, P and Judson, I (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) 1561 - 1570. 10.1158/1078-0432.CCR-10-1927.

Plummer, R and Wilson, RH and Calvert, H and Boddy, AV and Griffin, M and Sludden, J and Tilby, MJ and Eatock, M and Pearson, DG and Ottley, CJ and Matsumura, Y and Kataoka, K and Nishiya, T (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Puzanov, I and Lee, W and Chen, AP and Calcutt, MW and Hachey, DL and Vermeulen, WL and Spanswick, VJ and Liao, CY and Hartley, JA and Berlin, JD and Rothenberg, ML (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

R

Rajkumar, V and Dearling, JL and Packard, A and Pedley, RB (2011) Radioimmunotherapy: optimizing delivery to solid tumors. Ther Deliv , 2 (5) 567 - 572.

Ran, Y and Ethaar, E-E and Vineeth, R and Mathew, R and Barbara, PR and Erik, A (2011) One-pot Formation of a I-125-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS , 54 S57 - S57.

Reid, JM and Buhrow, SA and Kuffel, MJ and Jia, L and Spanswick, VJ and Hartley, JA and Thurston, DE and Tomaszewski, JE and Ames, MM (2011) Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. CANCER CHEMOTH PHARM , 68 (3) 777 - 786. 10.1007/s00280-010-1517-4.

Rustin, G and Reed, N and Jayson, GC and Ledermann, JA and Adams, M and Perren, T and Poole, C and Lind, M and Persic, M and Essapen, S and Gore, M and Calvert, H and Stredder, C and Wagner, A and Giurescu, M and Kaye, S (2011) A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (11) 2411 - 2416. 10.1093/annonc/mdq780.

S

Salazar, R and Plummer, R and Oaknin, A and Robinson, A and Pardo, B and Soto-Matos, A and Yovine, A and Szyldergemajn, S and Calvert, AH (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Saravanan, K and Barlow, HC and Barton, M and Calvert, AH and Golding, BT and Newell, DR and Northen, JS and Curtin, NJ and Thomas, HD and Griffin, RJ (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Short, SC and Giampieri, S and Worku, M and German, M and Sioftanos, G and Bourne, S (2011) Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumour derived cells. Neuro-Oncology , 13 (5) 487 - 499.

Siddiqui, GK and Maclean, AB and Elmasry, K and Fong, AWT and Morris, RW and Rashid, M and Begent, RHJ and Boxer, GM (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Sims, D and Mendes-Pereira, AM and Frankum, J and Burgess, D and Cerone, MA and Lombardelli, C and Mitsopoulos, C and Hakas, J and Murugaesu, N and Isacke, CM and Fenwick, K and Assiotis, I and Kozarewa, I and Zvelebil, M and Ashworth, A and Lord, CJ (2011) High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol , 12 (10) R104 - ?. 10.1186/gb-2011-12-10-r104.

Sivabalasingham, S and Fersht, N and D'Souza, D and Rosenberg, I and Stacey, C and Davies, P and Guerro-Urbano, T and Short, S (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smith, SW and Eardley, KS and Croft, AP and Nwosu, J and Howie, AJ and Cockwell, P and Isacke, CM and Buckley, CD and Savage, CO (2011) CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int , 80 (2) 199 - 207. 10.1038/ki.2011.103.

Spencer, J and Amin, J and Coxhead, P and McGeehan, J and Richards, CJ and Tizzard, GJ and Coles, SJ and Bingham, JP and Hartley, JA and Feng, L and Meggers, E and Guille, M (2011) Size Does Matter. Sterically Demanding Metallocene-Substituted 3-Methylidene-Oxindoles Exhibit Poor Kinase Inhibitory Action. ORGANOMETALLICS , 30 (11) 3177 - 3181. 10.1021/om200278j.

T

Taylor, RM and Grieve, A and Gibson, F and Dhawan, A and Franck, LS (2011) Parental assessment of adolescent quality of life: can it replace self-assessment? Qual Life Res , 20 (10) 1715 - 1720. 10.1007/s11136-011-9904-9.

Thirlwell, C and Schulz, L and Eymard, M and Luong, TV and Meyer, T and Davidson, B and Teschendorff, A and Jiao, Y and Caplin, M and Beck, S (2011) Integrated Genome-Wide DNA Methylation and mRNA Expression Analysis of Pancreatic NETs Identifies Differential Activation of the Hypoxia Inducible Factor (HIF) Pathway between Low and Intermediate Grade Tumors. In: NEUROENDOCRINOLOGY. (pp. 12 - 13).

V

van Zyl-Smit, RN and Binder, A and Meldau, R and Mishra, H and Semple, PL and Theron, G and Peter, J and Whitelaw, A and Sharma, SK and Warren, R and Bateman, ED and Dheda, K (2011) Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden. PLOS ONE , 6 (12) , Article e28815. 10.1371/journal.pone.0028815.
An open access publication. A version is also available from UCL Discovery.
 file

Vazquez, I and Bridgewater, J (2011) Nonsurgical therapy of biliary tract cancer. Curr Opin Gastroenterol , 27 (3) 258 - 261. 10.1097/MOG.0b013e3283454f09.

W

Wang, AT and Sengerova, B and Cattell, E and Inagawa, T and Hartley, JM and Kiakos, K and Burgess-Brown, NA and Swift, LP and Enzlin, JH and Schofield, CJ and Gileadi, O and Hartley, JA and McHugh, PJ (2011) Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. GENE DEV , 25 (17) 1859 - 1870. 10.1101/gad.15699211.

Westbury, CB and Sahlberg, KK and Borresen-Dale, AL and Isacke, CM and Yarnold, JR (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42.
An open access publication

Whelan, JS and Gelderblom, AH and Jinks, R and Sydes, M and Bramwell, VH and van Glabbeke, M and Grimer, RJ and Hogendoorn, PCW and McTiernan, A and Lewis, I and Noolji, M and Taminiau, AHM (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup randomised controlled trials. Eur J Cancer (47) 895 - 902.

Whelan, JS and Jinks, RC and McTiernan, A and Sydes, MR and Hook, JM and Trani, L and Uscinska, B and Bramwell, B and Lewis, IJ and Nooij, M and van Glabbeke, M and Grimer, RJ and Hogendoorn, PCW and Taminiau, AHM and Gelderblom, H (2011) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 10.1093/annonc/mdr491.

Whelan, JS and Miller, R (2011) Lung carcinoma with hypertropic osteoarthropathy in a teenager. Rare Tumours , 3:e8

Y

Yan, R and El-Emir, E and Rajkumar, V and Robson, M and Jathoul, AP and Pedley, RB and Arstad, E (2011) One-Pot Synthesis of an I-125-Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. ANGEW CHEM INT EDIT , 50 (30) 6793 - 6795. 10.1002/anie.201102072.

Yogev, O and Lagos, D (2011) Noncoding RNAs and cancer. Silence , 2 (1) 6 - ?. 10.1186/1758-907X-2-6.
An open access publication

Yogev, O and Naamati, A and Pines, O (2011) Fumarase: a paradigm of dual targeting and dual localized functions. FEBS J , 278 (22) 4230 - 4242. 10.1111/j.1742-4658.2011.08359.x.

Yogev, O and Pines, O (2011) Dual targeting of mitochondrial proteins: Mechanism, regulation and function. BBA-BIOMEMBRANES , 1808 (3) 1012 - 1020. 10.1016/j.bbamem.2010.07.004.

Yong, MY and Gonzalez-Beltran, A and Begent, R (2011) Establishing a knowledge trail from molecular experiments to clinical trials. NEW BIOTECHNOL , 28 (5) 464 - 480. 10.1016/j.nbt.2011.03.016.

Z

Zhang, EZ and Povazay, B and Laufer, J and Alex, A and Hofer, B and Pedley, B and Glittenberg, C and Treeby, B and Cox, B and Beard, P and Drexler, W (2011) Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. Biomed Opt Express , 2 (8) 2202 - 2215. 10.1364/BOE.2.002202.

This list was generated on Sun May 19 07:09:20 2013 BST.